Government invites drugmakers to register for 2,000-acre LePIP facility

The Ghanaian government has officially opened registration for pharmaceutical manufacturers to establish operations at the Legon Pharmaceutical Innovation Park (LePIP), a sprawling 2,000-acre facility located in Ningo Prampram. This initiative, spearheaded by the 24-Hour Economy and Accelerated Export Development (24H+) Authority in collaboration with the Ghana Infrastructure and Investment Fund (GIIF), represents a significant step toward industrializing the health sector. Interested companies have been invited to submit their expressions of interest immediately to facilitate the project's development phase. LePIP is designed to provide comprehensive infrastructure and utilities tailored to the specific needs of the pharmaceutical industry. The park will house companies specializing in the production of active pharmaceutical ingredients (APIs), generic medications, and vaccines. By centralizing these operations, the government aims to transform Ghana into a regional manufacturing and export hub, significantly reducing the nation's heavy reliance on imported drugs. The project is further bolstered by technical and strategic support from the UK-funded Ghana Jobs and Economic Transformation (JET) Programme, ensuring that the facility meets international standards for pharmaceutical manufacturing. Beyond industrial capacity, the innovation park is a central pillar of the government's job creation strategy under the 24-Hour Economy policy. Officials estimate that the full operationalization of LePIP will generate approximately 30,000 direct and indirect jobs, providing a substantial boost to the local economy in Ningo Prampram and surrounding areas. By fostering an environment conducive to large-scale production and export, the initiative seeks to stabilize the pharmaceutical supply chain while positioning Ghana as a leader in medical self-sufficiency within the West African sub-region.